John Fruehauf

John Fruehauf is a Professor of Clinical Medicine and Director of Clinical Pharmacology and Developmental Therapeutics, Chao Family Comprehensive Cancer Research Center, Univ of California, Irvine. He has an extensive track record of governmental and industry grants and cancer-related patents.  Previously, John was a chemotherapy resistance research at the NCI, Chief Scientific Officer at Oncotech, developer of the extreme drug resistance assay. MD/Ph.D. from Rush University.